Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
4
Next >
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
Roche Holding AG
Novartis AG
Business News
From
CNBC.com News
FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
July 21, 2025
Tags
Companies
Biotechnology
Amgen Inc
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Health & Science
Vertex Pharmaceuticals Inc
Pfizer Inc
From
CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025
Tags
Breaking News: Business
Earnings
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Monday
February 10, 2025
Tags
Politics
Technology
CVS Health Corp
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
Eisai Co Ltd
Biotechnology
Companies
From
CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024
Tags
Health & Science
Breaking News: Earnings
Pharmaceuticals
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
New York Times Co
Stock markets
Amgen Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Pfizer Inc
Snap Inc
Politics
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
September 25, 2024
Tags
Parker/Hannifin Corp
Micron Technology Inc
Investing
From
CNBC.com News
5 things to know before the stock market opens Monday
September 09, 2024
Tags
Eisai Co Ltd
Technology
Politics
From
CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
September 08, 2024
Tags
US: News
Business
Pharmaceuticals
From
CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
US: News
Business
Pharmaceuticals
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Pharmaceuticals
Science
Health & Science
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Biogen Inc
Business News
Biotech and Pharmaceuticals
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Biotechnology
Companies
Eisai Co Ltd
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Stock Picks
Eisai Co Ltd
Investment Strategy
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
Bank of America Corp
U/S/ Markets
Fidelis Insurance Holdings Ltd
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Business
Biotech and Pharmaceuticals
US: News
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Investing
Mattel Inc
Business News
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Biogen Inc
Companies
Biotechnology
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Science
Health & Science
Health care industry
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Business
US: News
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Markets
Business News
DoorDash Inc
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Companies
Biotechnology
Eisai Co Ltd
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Pharmaceuticals
Pfizer Inc
Eli Lilly and Co
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
Rivian Automotive Inc
Walt Disney Co
Business
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Health care industry
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
Business News
Biogen Inc
Drug approvals
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
Sweetgreen Inc
Biogen Inc
AstraZeneca PLC
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.